Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule

Rhea-AI Summary

Maravai LifeSciences (NASDAQ: MRVI) announces participation in two key investor conferences. On November 8, 2022, CFO Kevin Herde and COO Brian Neel will engage in a fireside chat at the Credit Suisse Healthcare Conference in California. Subsequently, on December 6, 2022, Mr. Herde will present at the Nasdaq Investor Conference in London, UK. Live webcasts will be accessible via their Investor Relations website, with archived versions available post-event. Maravai is a key provider of life science reagents supporting drug therapy and diagnostics development.

Positive

• Participation in two high-profile investor conferences could enhance investor relations and visibility.
• Webcasts provide transparent communication to stakeholders, potentially increasing investor confidence.

Negative

• None.

SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the months of November and December.

On November 8^th, 2022, at 12:50 p.m. PST, Kevin Herde, Chief Financial Officer, and Brian Neel, Chief Operating Officer, Nucleic Acid Production, will participate in a fireside chat at the Credit Suisse Healthcare Conference being held in Rancho Palos Verdes, California.

On December 6^th at 10:00 a.m. GMT, Mr. Herde will present at the Nasdaq Investor Conference held in Association with Morgan Stanley taking place in London, UK.

A live webcast of the presentations will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under Events and Presentations. An archived version of the webcasts will also be available on the Maravai website following the completion of each event.

About Maravai

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.

For more information about Maravai LifeSciences, visit www.maravai.com.

FAQ

When is Maravai LifeSciences presenting at the Credit Suisse Healthcare Conference?

Maravai LifeSciences will present on November 8, 2022, at 12:50 p.m. PST.

What is the date of Maravai LifeSciences' presentation at the Nasdaq Investor Conference?

Maravai LifeSciences will present on December 6, 2022, at 10:00 a.m. GMT.

Where can I watch the live webcasts of Maravai LifeSciences' presentations?

Live webcasts will be available on the Maravai LifeSciences Investor Relations website.

What is the significance of Maravai's participation in these investor conferences?

Participation may improve investor relations and increase market visibility for Maravai LifeSciences.

Who are the executives representing Maravai at the investor conferences?

CFO Kevin Herde and COO Brian Neel will represent Maravai at the Credit Suisse Healthcare Conference.